Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma.
Clin Pharmacokinet
; 57(4): 529-538, 2018 04.
Article
in En
| MEDLINE
| ID: mdl-28983805
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Agents, Immunological
/
Antibodies, Monoclonal
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Pharmacokinet
Year:
2018
Type:
Article
Affiliation country:
United States